ANDA 210190, held by Glenmark Pharms Ltd. Clobetasol Propionate.
As of Nov 15, 2026, ANDA 210190 (Clobetasol Propionate), held by Glenmark Pharms Ltd, was first approved by FDA on Apr 18, 2018, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 18, 2018 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clobetasol Propionate0.05% ยท solution;topical | Clobetasol Propionate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
